// App-Quantinova.ai

DISP-01 : IMMUNOTHERAPY ADMINISTRATION RATES IN PATIENTS WITH BRAIN METASTASES: IMPACT OF END STAGE RENAL DISEASE AND DIALYSIS

Researchers

Presenter

  • Angel Baroz

Principal Investigators

  • Debarati Bhanja

  • Caleb Stahl

  • Hannah Wilding

  • Alireza Mansouri

Medical Centers

  • Penn State Hershey Medical Center, Hershey, PA, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Brain cancer

  • End stage renal disease

  • Solid malignancies

  • Brain metastasis

  • Renal disease

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved